Skip to main content

15.05.2024 | Original Article

Evaluation of ventricular repolarization in dermatomyositis and relationship with inflammation and autoimmunity

verfasst von: Hui Wang, Ping Lin

Erschienen in: Heart and Vessels

Einloggen, um Zugang zu erhalten

Abstract

Dermatomyositis (DM) is a chronic multi-systemic inflammatory disorder of autoimmune origin, which has been associated with cardiovascular complications, including ventricular arrhythmias and sudden cardiac death. The Tp-e interval and Tp-e/QT ratio have been accepted as new markers for the assessment of myocardial repolarization and ventricular arrhythmogenesis. The aim of this study was to evaluate ventricular repolarization by using Tp-e interval and Tp-e/QT ratio in patients with DM, and to assess the relation with inflammation and autoimmunity. This study included 281 DM patients (180 females, 101 males; mean age 52.73 ± 15.80 years) and 281 control subjects (180 females, 101 males; mean age 53.38 ± 15.72 years). QTc, Tp-e interval and Tp-e/QT ratio were measured from the 12-lead ECG. The plasma level of blood routine test, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) was measured. These parameters were compared between groups. No statistically significant difference was found between two groups in terms of basic characteristics. In electrocardiographic parameters analysis, QTc, Tp-e interval and Tp-e/QT ratio were significantly increased in DM patients compared to the control group (441.44 ± 26.62 ms vs 422.72 ± 11.7 ms, 104.16 ± 24.34 ms vs 77.23 ± 16.25 ms and 0.27 ± 0.06 ms vs 0.20 ± 0.04 ms, all P value < 0.01). QTc, Tp-e interval and Tp-e/QT were positively correlated with NLR, CRP, and ESR (all P values < 0.01), and were increased in anti-Ro/SSA-52kD positive patients compared to those negative (452.33 ± 24.89 ms vs 438.55 ± 26.37 ms, 114.05 ± 22.68 ms vs 101.53 ± 24.13 ms, and 0.29 ± 0.06 ms vs 0.27 ± 0.05 ms, all P value < 0.01). Our study demonstrated that QTc, Tp-e interval, and Tp-e/QT ratio were increased in DM patients and were associated with inflammatory markers and anti-Ro/SSA-52kD positivity.
Literatur
1.
Zurück zum Zitat Lundberg IE (2021) Expert perspective: management of refractory inflammatory myopathy. Arthritis Rheumatol 73(8):1394–1407CrossRefPubMed Lundberg IE (2021) Expert perspective: management of refractory inflammatory myopathy. Arthritis Rheumatol 73(8):1394–1407CrossRefPubMed
2.
Zurück zum Zitat Zhao L, Wang Q, Zhou B, Zhang L, Zhu H (2021) The Role of Immune Cells in the Pathogenesis of Idiopathic Inflammatory Myopathies. Aging Dis 12(1):247–260CrossRefPubMedPubMedCentral Zhao L, Wang Q, Zhou B, Zhang L, Zhu H (2021) The Role of Immune Cells in the Pathogenesis of Idiopathic Inflammatory Myopathies. Aging Dis 12(1):247–260CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Schwartz T, Diederichsen LP, Lundberg IE, Sjaastad I, Sanner H (2016) Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies. RMD Open 2(2):e000291CrossRefPubMedPubMedCentral Schwartz T, Diederichsen LP, Lundberg IE, Sjaastad I, Sanner H (2016) Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies. RMD Open 2(2):e000291CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Kors JA, Ritsema van Eck HJ, van Herpen G (2008) The meaning of the Tp-Te interval and its diagnostic value. J Electrocardiol 41(6):575–580CrossRefPubMed Kors JA, Ritsema van Eck HJ, van Herpen G (2008) The meaning of the Tp-Te interval and its diagnostic value. J Electrocardiol 41(6):575–580CrossRefPubMed
5.
Zurück zum Zitat Erikssen G, Liestøl K, Gullestad L, Haugaa KH, Bendz B, Amlie JP (2012) The terminal part of the QT interval (T peak to T end): a predictor of mortality after acute myocardial infarction. Ann Noninvasive Electrocardiol 17(2): 85–94. Erikssen G, Liestøl K, Gullestad L, Haugaa KH, Bendz B, Amlie JP (2012) The terminal part of the QT interval (T peak to T end): a predictor of mortality after acute myocardial infarction. Ann Noninvasive Electrocardiol 17(2): 85–94.
6.
Zurück zum Zitat Antzelevitch C, Sicouri S, Di Diego JM, Burashnikov A, Viskin S, Shimizu W, Yan GX, Kowey P, Zhang L (2007) Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm 4(8):1114–1119CrossRefPubMedPubMedCentral Antzelevitch C, Sicouri S, Di Diego JM, Burashnikov A, Viskin S, Shimizu W, Yan GX, Kowey P, Zhang L (2007) Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm 4(8):1114–1119CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Drew BJ, Ackerman MJ, Funk M., Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W, American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, Council on Cardiovascular Nursing, American College of Cardiology Foundation (2010) Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 55(9): 934–947 Drew BJ, Ackerman MJ, Funk M., Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W, American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, Council on Cardiovascular Nursing, American College of Cardiology Foundation (2010) Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 55(9): 934–947
8.
Zurück zum Zitat Ye M, Zhang JW, Liu J, Zhang M, Yao FJ, Cheng YJ (2021) Association between dynamic change of QT interval and long-term cardiovascular outcomes: a prospective cohort study. Front Cardiovasc Med 8:756213CrossRefPubMedPubMedCentral Ye M, Zhang JW, Liu J, Zhang M, Yao FJ, Cheng YJ (2021) Association between dynamic change of QT interval and long-term cardiovascular outcomes: a prospective cohort study. Front Cardiovasc Med 8:756213CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Tse G (2016) Novel conduction-repolarization indices for the stratification of arrhythmic risk. J Geriatr Cardiol JGC 13(9):811–812PubMed Tse G (2016) Novel conduction-repolarization indices for the stratification of arrhythmic risk. J Geriatr Cardiol JGC 13(9):811–812PubMed
10.
Zurück zum Zitat Tse G, Yan BP (2017) Traditional and novel electrocardiographic conduction and repolarization markers of sudden cardiac death. Europace 19(5):712–721CrossRefPubMed Tse G, Yan BP (2017) Traditional and novel electrocardiographic conduction and repolarization markers of sudden cardiac death. Europace 19(5):712–721CrossRefPubMed
11.
Zurück zum Zitat Rider LG, Ruperto N, Pistorio A, Erman B, Bayat N, Lachenbruch PA, Rockette H, Feldman BM, Huber AM, Hansen P, Oddis CV, Lundberg IE, Amato AA, Chinoy H, Cooper RG, Chung L, Danko K, Fiorentino D, García-De la Torre I, Reed AM, Wook Song Y, Cimaz R, Cuttica RJ, Pilkington CA, Martini A, van der Net J, Maillard S, Miller FW, Vencovsky J, Aggarwal R, International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation (2017) 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects. Rheumatology (Oxford) 56(11): 1884–1893 Rider LG, Ruperto N, Pistorio A, Erman B, Bayat N, Lachenbruch PA, Rockette H, Feldman BM, Huber AM, Hansen P, Oddis CV, Lundberg IE, Amato AA, Chinoy H, Cooper RG, Chung L, Danko K, Fiorentino D, García-De la Torre I, Reed AM, Wook Song Y, Cimaz R, Cuttica RJ, Pilkington CA, Martini A, van der Net J, Maillard S, Miller FW, Vencovsky J, Aggarwal R, International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation (2017) 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects. Rheumatology (Oxford) 56(11): 1884–1893
12.
Zurück zum Zitat El-Sherif N, Turitto G, Boutjdir M (2018) Acquired long QT syndrome and torsade de pointes. Pacing Clin Electrophysiol PACE 41(4):414–421CrossRefPubMed El-Sherif N, Turitto G, Boutjdir M (2018) Acquired long QT syndrome and torsade de pointes. Pacing Clin Electrophysiol PACE 41(4):414–421CrossRefPubMed
13.
Zurück zum Zitat Khatib R, Sabir FRN, Omari C, Pepper C, Tayebjee MH (2021) Managing drug-induced QT prolongation in clinical practice. Postgrad Med J 97(1149):452–458CrossRefPubMed Khatib R, Sabir FRN, Omari C, Pepper C, Tayebjee MH (2021) Managing drug-induced QT prolongation in clinical practice. Postgrad Med J 97(1149):452–458CrossRefPubMed
16.
Zurück zum Zitat Naaraayan A, Meredith A, Nimkar A, Arora G, Bharati R, Acharya P (2021) Arrhythmia prevalence among patients with polymyositis-dermatomyositis in the United States: an observational study. Heart Rhythm 18(9):1516–1523CrossRefPubMed Naaraayan A, Meredith A, Nimkar A, Arora G, Bharati R, Acharya P (2021) Arrhythmia prevalence among patients with polymyositis-dermatomyositis in the United States: an observational study. Heart Rhythm 18(9):1516–1523CrossRefPubMed
17.
Zurück zum Zitat Danieli MG, Gelardi C, Guerra F, Cardinaletti P, Pedini V, Gabrielli A (2016) Cardiac involvement in polymyositis and dermatomyositis. Autoimmun Rev 15(5):462–465CrossRefPubMed Danieli MG, Gelardi C, Guerra F, Cardinaletti P, Pedini V, Gabrielli A (2016) Cardiac involvement in polymyositis and dermatomyositis. Autoimmun Rev 15(5):462–465CrossRefPubMed
18.
Zurück zum Zitat Zhang L, Wang GC, Ma L, Zu N (2012) Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol 35(11):686–691PubMed Zhang L, Wang GC, Ma L, Zu N (2012) Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol 35(11):686–691PubMed
19.
Zurück zum Zitat Karaman K, Altunkaş F, Çetin M, Karayakali M, Arısoy A, Akar I, Zencir C, Aygüç B, Çelik A (2015) New markers for ventricular repolarization in coronary slow flow: Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio. Ann Noninvasive Electrocardiol 20(4):338–344CrossRefPubMed Karaman K, Altunkaş F, Çetin M, Karayakali M, Arısoy A, Akar I, Zencir C, Aygüç B, Çelik A (2015) New markers for ventricular repolarization in coronary slow flow: Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio. Ann Noninvasive Electrocardiol 20(4):338–344CrossRefPubMed
20.
Zurück zum Zitat Indraratna P, Tardo D, Delves M, Szirt R, Ng B (2020) Measurement and management of QT interval prolongation for general physicians. J Gen Intern Med 35(3):865–873CrossRefPubMed Indraratna P, Tardo D, Delves M, Szirt R, Ng B (2020) Measurement and management of QT interval prolongation for general physicians. J Gen Intern Med 35(3):865–873CrossRefPubMed
21.
Zurück zum Zitat Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, Yan GX (2008) T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol 41(6):567–574CrossRefPubMed Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, Yan GX (2008) T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol 41(6):567–574CrossRefPubMed
22.
Zurück zum Zitat Mugnai G, Benfari G, Fede A, Rossi A, Chierchia GB, Vassanelli F, Menegatti G, Ribichini FL (2016) Tpeak-to-Tend/QT is an independent predictor of early ventricular arrhythmias and arrhythmic death in anterior ST elevation myocardial infarction patients. Eur Heart J Acute Cardiovasc Care 5(6):473–480CrossRefPubMed Mugnai G, Benfari G, Fede A, Rossi A, Chierchia GB, Vassanelli F, Menegatti G, Ribichini FL (2016) Tpeak-to-Tend/QT is an independent predictor of early ventricular arrhythmias and arrhythmic death in anterior ST elevation myocardial infarction patients. Eur Heart J Acute Cardiovasc Care 5(6):473–480CrossRefPubMed
23.
Zurück zum Zitat Xianpei W, Sha W, Chuanyu G, Juanjuan Y, Chong C, Yongen S, Yu F, Zhenhao L (2017) Tpeak-Tend dispersion as a predictor for malignant arrhythmia events in patients with vasospastic angina. Int J Cardiol 249:61–65CrossRefPubMed Xianpei W, Sha W, Chuanyu G, Juanjuan Y, Chong C, Yongen S, Yu F, Zhenhao L (2017) Tpeak-Tend dispersion as a predictor for malignant arrhythmia events in patients with vasospastic angina. Int J Cardiol 249:61–65CrossRefPubMed
24.
Zurück zum Zitat Acar GR, Akkoyun M, Nacar AB, Dirnak I, Yıldırım Çetin G, Nur Yıldırım M, Zencir C, Karaman K, Cetin M, Sayarlıoğlu M (2014) Evaluation of Tp-e interval and Tp-e/QT ratio in patients with rheumatoid arthritis. Turk Kardiyol Dern Ars 42(1):29–34CrossRefPubMed Acar GR, Akkoyun M, Nacar AB, Dirnak I, Yıldırım Çetin G, Nur Yıldırım M, Zencir C, Karaman K, Cetin M, Sayarlıoğlu M (2014) Evaluation of Tp-e interval and Tp-e/QT ratio in patients with rheumatoid arthritis. Turk Kardiyol Dern Ars 42(1):29–34CrossRefPubMed
25.
Zurück zum Zitat Lazzerini PE, Capecchi PL, Acampa M, Galeazzi M, Laghi-Pasini F (2014) Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. Autoimmun Rev 13(9):936–944CrossRefPubMed Lazzerini PE, Capecchi PL, Acampa M, Galeazzi M, Laghi-Pasini F (2014) Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. Autoimmun Rev 13(9):936–944CrossRefPubMed
26.
Zurück zum Zitat Soylu K, İnci S, Aksan G, Nar G, Yüksel EP, Ocal HS, Çapraz M, Yüksel S, Şahin M (2016) Evaluation of inhomogeneities of repolarization in patients with psoriasis vulgaris. Arch Med Sci 12(6):1225–1231CrossRefPubMedPubMedCentral Soylu K, İnci S, Aksan G, Nar G, Yüksel EP, Ocal HS, Çapraz M, Yüksel S, Şahin M (2016) Evaluation of inhomogeneities of repolarization in patients with psoriasis vulgaris. Arch Med Sci 12(6):1225–1231CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Acar G, Yorgun H, Inci MF, Akkoyun M, Bakan B, Nacar AB, Dirnak I, Cetin GY, Bozoglan (2014) Evaluation of Tp-e interval and Tp-e/QT ratio in patients with ankylosing spondylitis. Mod Rheumatol 24(2):327–330CrossRefPubMed Acar G, Yorgun H, Inci MF, Akkoyun M, Bakan B, Nacar AB, Dirnak I, Cetin GY, Bozoglan (2014) Evaluation of Tp-e interval and Tp-e/QT ratio in patients with ankylosing spondylitis. Mod Rheumatol 24(2):327–330CrossRefPubMed
28.
Zurück zum Zitat Diederichsen LP, Simonsen JA, Diederichsen AC, Hvidsten S, Hougaard M, Junker P, Søndergaard K, Lundberg IE, Tvede N, Sandgaard NC, Christensen AF, Dreyer L, Kay S, Eskerud KS, Petersen H, Ejstrup L, Jacobsen S (2016) Cardiac abnormalities in adult patients with polymyositis or dermatomyositis as assessed by noninvasive modalities. Arthritis Care Res 68(7):1012–1020CrossRef Diederichsen LP, Simonsen JA, Diederichsen AC, Hvidsten S, Hougaard M, Junker P, Søndergaard K, Lundberg IE, Tvede N, Sandgaard NC, Christensen AF, Dreyer L, Kay S, Eskerud KS, Petersen H, Ejstrup L, Jacobsen S (2016) Cardiac abnormalities in adult patients with polymyositis or dermatomyositis as assessed by noninvasive modalities. Arthritis Care Res 68(7):1012–1020CrossRef
29.
Zurück zum Zitat Cantez S, Gross GJ, MacLusky I, Feldman BM (2017) Cardiac findings in children with juvenile Dermatomyositis at disease presentation. Pediatr Rheumatol Online J 15(1):54CrossRefPubMedPubMedCentral Cantez S, Gross GJ, MacLusky I, Feldman BM (2017) Cardiac findings in children with juvenile Dermatomyositis at disease presentation. Pediatr Rheumatol Online J 15(1):54CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Zahorec R (2021) Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy 122(7):474–488PubMed Zahorec R (2021) Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy 122(7):474–488PubMed
31.
Zurück zum Zitat Pritzker KPH (2023) Blood-based biomarkers of chronic inflammation. Expert Rev Mol Diagn 23(6):495–504CrossRefPubMed Pritzker KPH (2023) Blood-based biomarkers of chronic inflammation. Expert Rev Mol Diagn 23(6):495–504CrossRefPubMed
32.
Zurück zum Zitat Lazzerini PE, Abbate A, Boutjdir M, Capecchi PL (2023) Fir(e)ing the rhythm: inflammatory cytokines and cardiac arrhythmias. JACC Basic Transl Sci 8(6):728–750CrossRefPubMedPubMedCentral Lazzerini PE, Abbate A, Boutjdir M, Capecchi PL (2023) Fir(e)ing the rhythm: inflammatory cytokines and cardiac arrhythmias. JACC Basic Transl Sci 8(6):728–750CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Lazzerini PE, Capecchi PL, El-Sherif N, Laghi-Pasini F, Boutjdir M (2018) Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies. J Am Heart Assoc 7(22):e010595CrossRefPubMedPubMedCentral Lazzerini PE, Capecchi PL, El-Sherif N, Laghi-Pasini F, Boutjdir M (2018) Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies. J Am Heart Assoc 7(22):e010595CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Adlan AM, Panoulas VF, Smith JP, Fisher JP, Kitas GD (2015) Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis. J Rheumatol 42(3):421–428CrossRefPubMed Adlan AM, Panoulas VF, Smith JP, Fisher JP, Kitas GD (2015) Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis. J Rheumatol 42(3):421–428CrossRefPubMed
35.
Zurück zum Zitat Lazzerini PE, Acampa M, Laghi-Pasini F, Bertolozzi I, Finizola F, Vann F, Natale M, Bisogno S, Cevenini G, Cartocci A, Giabbani B, Migliacci N, D’Errico A, Dokollari A, Maccherini M, Boutjdir M, Capecchi PL (2020) Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression. Circ Arrhythm Electrophysiol 13(8):e008627CrossRefPubMed Lazzerini PE, Acampa M, Laghi-Pasini F, Bertolozzi I, Finizola F, Vann F, Natale M, Bisogno S, Cevenini G, Cartocci A, Giabbani B, Migliacci N, D’Errico A, Dokollari A, Maccherini M, Boutjdir M, Capecchi PL (2020) Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression. Circ Arrhythm Electrophysiol 13(8):e008627CrossRefPubMed
36.
37.
Zurück zum Zitat Lazzerini PE, Capecchi PL, Laghi-Pasini F, Boutjdir M (2017) Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias. Nat Rev Cardiol 14(9):521–535CrossRefPubMed Lazzerini PE, Capecchi PL, Laghi-Pasini F, Boutjdir M (2017) Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias. Nat Rev Cardiol 14(9):521–535CrossRefPubMed
38.
Zurück zum Zitat Lazzerini PE, Cevenini G, Qu YS, Fabris F, El-Sherif N, Acampa M, Cartocci A, Laghi-Pasini F, Capecchi PL, Boutjdir M, Lazaro D (2021) Risk of QTc interval prolongation associated with circulating anti-Ro/SSA antibodies among US Veterans: an observational cohort study. J Am Heart Assoc 10(4):e018735CrossRefPubMedPubMedCentral Lazzerini PE, Cevenini G, Qu YS, Fabris F, El-Sherif N, Acampa M, Cartocci A, Laghi-Pasini F, Capecchi PL, Boutjdir M, Lazaro D (2021) Risk of QTc interval prolongation associated with circulating anti-Ro/SSA antibodies among US Veterans: an observational cohort study. J Am Heart Assoc 10(4):e018735CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL (2019) Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol 19(1):63–64CrossRefPubMed Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL (2019) Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol 19(1):63–64CrossRefPubMed
40.
Zurück zum Zitat Tufan AN, Sag S, Oksuz MF, Ermurat S, Coskun BN, Gullulu M, Budak F, Baran I, Pehlivan Y, Dalkilic E (2017) Prolonged Tpeak-Tend interval in anti-Ro52 antibody-positive connective tissue diseases. Rheumatol Int 37(1):67–73CrossRefPubMed Tufan AN, Sag S, Oksuz MF, Ermurat S, Coskun BN, Gullulu M, Budak F, Baran I, Pehlivan Y, Dalkilic E (2017) Prolonged Tpeak-Tend interval in anti-Ro52 antibody-positive connective tissue diseases. Rheumatol Int 37(1):67–73CrossRefPubMed
41.
Zurück zum Zitat Yue Y, Castrichini M, Srivastava U, Fabris F, Shah K, Li Z, Qu Y, El-Sherif N, Zhou Z, January C, Hussain MM, Jiang XC, Sobie EA, Wahren-Herlenius M, Chahine M, Capecchi PL, Laghi-Pasini F, Lazzerini PE, Boutjdir M (2015) Pathogenesis of the novel autoimmune-associated long-QT syndrome. Circulation 132(4):230–240CrossRefPubMed Yue Y, Castrichini M, Srivastava U, Fabris F, Shah K, Li Z, Qu Y, El-Sherif N, Zhou Z, January C, Hussain MM, Jiang XC, Sobie EA, Wahren-Herlenius M, Chahine M, Capecchi PL, Laghi-Pasini F, Lazzerini PE, Boutjdir M (2015) Pathogenesis of the novel autoimmune-associated long-QT syndrome. Circulation 132(4):230–240CrossRefPubMed
42.
Zurück zum Zitat Szendrey J, Lamothe SM, Vanner S, Guo J, Yang T, Li W, Davis J, Joneja M, Baranchuk A, Zhang S (2019) Anti-Ro52 antibody acts on the S5-pore linker of hERG to chronically reduce channel expression. Cardiovasc Res 115(10):1500–1511PubMed Szendrey J, Lamothe SM, Vanner S, Guo J, Yang T, Li W, Davis J, Joneja M, Baranchuk A, Zhang S (2019) Anti-Ro52 antibody acts on the S5-pore linker of hERG to chronically reduce channel expression. Cardiovasc Res 115(10):1500–1511PubMed
43.
Zurück zum Zitat Lazzerini PE, Yue Y, Srivastava U, Fabris F, Capecchi PL, Bertolozzi I, Bacarelli MR, Morozzi G, Acampa M, Natale M, El-Sherif N, Galeazzi M, Laghi-Pasini F, Boutjdir M (2016) Arrhythmogenicity of anti-Ro/SSA antibodies in patients with Torsades de Pointes. Circ Arrhythm Electrophysiol 9(4):e003419CrossRefPubMed Lazzerini PE, Yue Y, Srivastava U, Fabris F, Capecchi PL, Bertolozzi I, Bacarelli MR, Morozzi G, Acampa M, Natale M, El-Sherif N, Galeazzi M, Laghi-Pasini F, Boutjdir M (2016) Arrhythmogenicity of anti-Ro/SSA antibodies in patients with Torsades de Pointes. Circ Arrhythm Electrophysiol 9(4):e003419CrossRefPubMed
Metadaten
Titel
Evaluation of ventricular repolarization in dermatomyositis and relationship with inflammation and autoimmunity
verfasst von
Hui Wang
Ping Lin
Publikationsdatum
15.05.2024
Verlag
Springer Japan
Erschienen in
Heart and Vessels
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-024-02413-6

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.